Miguel A.Alvarez

Associate

圣地亚哥 + 1.858.314.1189

Miguel Alvarez's practice focuses on patent, trademark, and consumer litigation.

Miguel has extensive experience in the biotechnology and life sciences industry. Miguel's patent litigation practice has involved technologies such as gene therapy and pharmaceutical cancer drugs. He has also leveraged his experience in biotechnology to assist clients in disputes relating to circulating tumor DNA detection assays.

In addition, Miguel has brokered and facilitated favorable settlements in several consumer litigation matters.

Prior to joining Jones Day, Miguel spent eight years as a researcher at a San Diego-based biotechnology company where he led the research and development of novel antibody reagents and other cell-based assay reagents. He negotiated agreements involving the transfer of sensitive research materials on behalf of a nonprofit medical research institute as well.

Miguel also actively supports the Firm's pro bono initiatives, including assisting clients with navigating asylum proceedings with Jones Day's Border Project.

经验

  • Pharmaceutical company wins $107.5 million jury verdict in patent dispute involving AstraZeneca's lung cancer treatment Tagrisso®Jones Day on behalf of a pharmaceutical company won a jury award of $107.5 million in damages after a five-day trial and less than three hours of jury deliberation.
  • Cohesity disposes of six-patent litigation brought by adverse competitor CommvaultJones Day successfully represented Cohesity Inc. ("Cohesity") and obtained dismissal in a six-patent, competitor suit filed by Commvault Systems in April 21, 2020.
  • 其他出版物

    • September 2021
      Didn’t Cut the Mustard: PTAB Finds Claims Lacked Written Description and Enablement